LENZ Therapeutics’ Presbyopia Eye Drop VIZZ to Enter Greater China Market Through Everest Medicines Agreement
SAN DIEGO—LENZ Therapeutics Inc. (Nasdaq: LENZ), a pharmaceutical company focused on commercializing VIZZ (aceclidine ophthalmic solution) 1.44%, the first and only aceclidine-based eye drop for the treatment of…


